Chinese Biotech YS Biopharma's Next-Gen Rabies Vaccine Non-Inferior To Approved Competitor

Retrieved on: 2024-04-09 21:14:08

Tags for this article:

Click the tags to see associated articles and topics

Chinese Biotech YS Biopharma's Next-Gen Rabies Vaccine Non-Inferior To Approved Competitor. View article details on hiswai:

Excerpt

YS Biopharma unveils interim results from Phase 3 trial of PIKA Rabies Vaccine, meeting primary endpoints. With accelerated immunity in 7 days, ...

Article found on: www.benzinga.com